Buy 2 get 1 free — everything calculated at checkout
2900

Current Advances in Osteosarcoma

$32.00 Lowest price online — guaranteed

Price comparison

Publisher / Official store
$110.00
Our store
$32.00

Buy 2, get 1 free. Everything is calculated automatically at checkout.

Enter a valid email at checkout. Your ebook download link is sent to the email address you provide — double-check it before completing your order.

30-day money-back guarantee. File issue? We replace it or refund you — no questions asked.

IMPORTANT

Digital product — no physical item will be shipped

You'll receive a PDF download link by email immediately after checkout.

Can't find the ebook you're looking for?

Send us the book cover image via the live chat on our website and we'll request it for you. Estimated response time: 10 minutes.

Book details

Format
PDF — instant download
Language
English

About this book

⚠️📚THIS ISN'T A PHYSICAL BOOK!

Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.

About the Author

Eugenie S. Kleinerman, M.D. is Professor and Head of the Division of Pediatrics, the first women Division Head at MD Anderson Cancer Center. She is board certified in pediatrics, holds the Mosbacher Pediatrics Chair and is also a Professor of Cancer Biology. Dr. Kleinerman is internationally recognized for her scientific and clinical expertise in sarcomas, particularly osteosarcoma. She pioneered the use of a unique immunotherapy agent liposome-encapsulated MTP-PE, for children with unresponsive relapsed osteosarcoma lung metastases. Dr. Kleinerman has served on numerous NCI study sections and was a prior member of an FDA advisory panel. She has authored over 177 articles and 21 book chapters and has received over 2900 citations. In 2006, her achievements were recognized by her alma mater, Duke University Medical Center, where she received the Distinguished Medical Alumnus Award. She is the 2009 recipient of the Faculty Achievement Award in Clinical Research.

Author Eugenie S. Kleinerman, M.D. (Editor)
ISBN-13 9783319048437
Publisher Springer-Verlag New York, LLC
Publication Date 06/12/2014
Series Advances in Experimental Medicine and Biology
Page Count 359 pages

Why buy from us

  • 100% Authorised by publisher — licensed copy, never pirated
  • –84% Less than Amazon Kindle — lowest price guaranteed
  • Instant PDF delivered the moment your payment clears, 24/7
  • Full Complete edition — every chapter, no missing pages
Secure Checkout
Instant Download
24/7 Support

You may also like